Xencor (XNCR) Change in Account Payables (2013 - 2026)
Xencor's (XNCR) quarterly Change in Account Payables came in at -$2.9 million in Q1 2026, down 405.46% year-on-year from $939900.9 in Q1 2025, and down 269.78% on a QoQ basis from $1.7 million in Q4 2025.
Xencor (XNCR) Change in Account Payables (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Change in Account Payables data on file, last reported at -$2.9 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 405.46% year-over-year to -$2.9 million in Q1 2026; TTM through Mar 2026 was -$6.3 million, a 3575.56% decrease from a year earlier, with the FY2025 full-year figure at -$4.0 million, down 238.95% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$2.9 million, down from $1.7 million in the prior quarter.
- Over the last five years, Change in Account Payables for XNCR reached as high as $5.3 million in Q1 2023 and fell as low as -$9.5 million in Q3 2025.
- Historically, Change in Account Payables has averaged -$239176.5 across 5 years, with a median of -$568000.0 in 2025.
- On a YoY basis, Change in Account Payables climbed as much as 2630.64% in 2025 and fell as far as 422.44% in 2025.
- Year by year, Change in Account Payables stood at -$4.5 million in 2022, then soared by 76.75% to -$1.1 million in 2023, then sank by 90.98% to -$2.0 million in 2024, then jumped by 184.09% to $1.7 million in 2025, then tumbled by 269.78% to -$2.9 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$2.9 million in Q1 2026, $1.7 million in Q4 2025, and -$9.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - | -2.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.87 Mn |
| Mar 31, 2026 | -2.87 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | -9.45 Mn |
| Sep 30, 2025 | -9.45 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | -568,000.00 |
| Mar 31, 2025 | -568,000.00 |
| Dec 31, 2024 | -2.01 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | -173,000.00 |
| Jun 30, 2024 | -173,000.00 |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | -1.05 Mn |
| Dec 31, 2023 | -1.05 Mn |